Rule 424(b)(3)
Registration No. 333-08357
IONICS, INCORPORATED
__________________________________________________________________________
145,754 Shares
Common Stock
__________________________________________________________________________
This Prospectus relates to the offer and sale of up to an aggregate of
145,754 shares of Common Stock, $1.00 par value per share (the "Shares"),
of Ionics, Incorporated ("Ionics" or the "Company"), by 41 Company
shareholders (the "Selling Shareholders"). The Selling Shareholders may
sell the Shares at market prices prevailing at the time of the sale or at
prices otherwise negotiated, or may transfer a portion of the Shares by way
of gift. See "PLAN OF DISTRIBUTION." The Selling Shareholders and certain
persons who purchase shares from them, including broker-dealers acting as
principals who may resell the Shares, may be deemed "underwriters," as that
term is defined in the Securities Act of 1933, as amended (the "Securities
Act"). See "PLAN OF DISTRIBUTION" and "SELLING SHAREHOLDERS."
None of the proceeds from the resale of the Shares will be received by
the Company. The Company is responsible for the expenses incurred in
connection with the registration of the Shares. The Selling Shareholders
and will pay or assume brokerage commissions or other similar charges
incurred in the sale of the Shares. The Company has agreed to indemnify
the Selling Shareholders against certain liabilities, including liabilities
under the Securities Act.
The Company's Common Stock is traded on the New York Stock Exchange
under the symbol "ION." The last reported sale price for the Common Stock
on July 24, 1996 was $41.75, as reported by the New York Stock Exchange.
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY
THE SECURITIES AND EXCHANGE COMMISSION OR ANY STATE SECURITIES
COMMISSION NOR HAS THE SECURITIES AND EXCHANGE COMMISSION OR ANY
STATE SECURITIES COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.
No person has been authorized to give any information or to make any
representation other than those contained in this Prospectus in
connection with the offering made hereby, and if given or made, such
information or representation must not be relied upon as having been
authorized by the Company. Neither the delivery of this Prospectus nor
any sale made hereunder shall, under any circumstances, create any
implication that information herein is correct as of any time subsequent
to the date hereof.
The date of this Prospectus is July 25, 1996.
-1-
AVAILABLE INFORMATION
The Company is subject to the informational requirements of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and in
accordance therewith files reports, proxy statements and other
information with the Securities and Exchange Commission (the
"Commission"). Such reports, proxy statements and other information are
available for inspection and copying at the public reference facilities
maintained by the Commission at 450 5th Street, N.W., Washington, D.C.
20549, and at the following regional offices of the Commission: 75 Park
Place, 14th Floor, New York, New York 10007 and 219 South Dearborn
Street, Room 1204, Chicago, Illinois 60604. Copies of such material can
also be obtained from the Public Reference Section of the Commission at
450 5th Street, N.W., Washington, D.C. 20549 at prescribed rates. The
Common Stock of the Company is listed for trading on the New York Stock
Exchange and such material may also be inspected and copied at the New
York Stock Exchange, 20 Broad Street, New York, New York.
The Company has filed with the Commission a Registration Statement on
Form S-3 (including all amendments thereto, the "Registration Statement")
under the Securities Act, with respect to the Common Stock offered
hereby. This Prospectus does not contain all information set forth in
the Registration Statement, certain parts of which are omitted in
accordance with the rules and regulations of the Commission. For further
information regarding the Company and the Common Stock offered hereby,
reference is hereby made to the Registration Statement and to the
exhibits and schedules filed therewith. Statements contained in this
Prospectus regarding the contents of any agreement or other document
filed as an exhibit to the Registration Statement are not necessarily
complete, and in each instance reference is made to the copy of such
agreement filed as an exhibit to the Registration Statement, each such
statement being qualified in all respects by such reference. The
Registration Statement, including the exhibits and schedules thereto, may
be inspected at the public reference facilities maintained by the
Commission at 450 Fifth Street, N.W., Room 1024, Washington, D.C. 20549
and copies of all or any part thereof may be obtained from such office
upon payment of the prescribed fees.
INFORMATION INCORPORATED BY REFERENCE
The following documents filed by the Company with the Commission
pursuant to the Exchange Act are incorporated in this Prospectus by
reference as of their respective dates (File No. 1-7211):
1. The Company's Annual Report on Form 10-K for the fiscal year ended
December 31, 1995;
2. Quarterly Report on Form 10-Q for the fiscal quarter ended March 31,
1996;
3. The section entitled "Description of Securities to be Registered"
contained in the Company's Registration Statement on Form 8-A filed
with the Commission on September 27, 1990.
-2-
All documents subsequently filed by the Company pursuant to Section
13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of
the offering made hereby, shall be deemed to be incorporated by reference
in this Prospectus from the date of filing of such documents. Any
statement contained in a document incorporated or deemed to be incorporated
by reference herein shall be deemed to be modified or superseded for
purposes of this Prospectus to the extent that a statement contained herein
or in any other subsequently filed document which is also deemed to be
incorporated by reference herein modifies or supersedes such statement.
Any such statement so modified or superseded shall not be deemed, except as
so modified or superseded, to constitute a part of this Prospectus.
The Company will provide without charge to each person to whom a
Prospectus is delivered, on the written or oral request of such person, a
copy of any or all of the documents described above (other than exhibits to
such documents). Requests for such copies should be directed to Stephen
Korn, Clerk, Ionics, Incorporated, 65 Grove Street, Watertown,
Massachusetts 02172 (telephone: 617-926-2500).
THE COMPANY
Ionics is a separations technology company involved worldwide in the
manufacture and sale of membranes and related equipment for the
purification, concentration, treatment and analysis of water and
wastewater, in the supply of purified water, food and chemical products,
and in the sale of bottled water and home water purifiers. The Company's
business activities are divided into three segments: membranes and related
equipment; water, food and chemical supply; and consumer products.
Ionics was incorporated in Massachusetts in 1948. The Company's
principal executive offices are located at 65 Grove Street, Watertown,
Massachusetts 02172 and its telephone number is (617) 926-2500.
USE OF PROCEEDS
The Company will not receive any of the proceeds from the sale of the
shares by the Selling Shareholders.
-3-
<TABLE>
SELLING SHAREHOLDERS
The following table sets forth certain information regarding beneficial
ownership of the Shares as of July 15, 1996 and the number of Shares which
may be offered for the account of the Selling Shareholders from time to
time:
<CAPTION>
Shares To Shares
Shares Beneficially be Sold Beneficially
Owned in the Owned After
Selling Shareholder Prior to the Offering Offering the Offering
<S> <C> <C> <C>
Gregory Abbott 3,376 1,350 2,026
Darwin Molecular
1631 220th Street S.E.
Bothell, WA 98021
Blaine Bateman 2,095 838 1,257
593 Juniper Court
Louisville, CO 80027
Stephen & Lisa Bennion 2,686 1,074 1,612
702 Woburn Ct.
Mountain View, CA 94040
Everette Brennan 252 100 152
201 Brennan Lane
Church Point, LA 70525-4850
Michael Carruthers 6,955 1,074 5,881
991 Sage Valley Road
Longmont, Colorado 80503
CVM Management, Inc. 1,746 700 1,046
4845 Pearl East Circle
Suite 300
Boulder, CO 80503
Carl A. Craig 209 84 125
148 Snyder Mountain Road
Evergreen, CO 80439
Ronald Davenport 698 279 419
1544 E. Weldosa Way
Superior, Colorado 80027
-4-
Shares To Shares
Shares Beneficially be Sold Beneficially
Owned in the Owned After
Selling Shareholder Prior to the Offering Offering the Offering
N.M. Rothschild and Sons 40,303 16,121 24,182
(C.I.) Limited as
Custodian for Biotechnology
Investments, Limited
c/o Jesse Treu
Domain Associates
One Palmer Square
Princeton, NJ 08542
Domain Partners. L.P. 40,303 16,121 24,182
c/o Jesse Treu
Domain Associates
One Palmer Square
Princeton, NJ 08542
Jay Flatley 2,686 200 2,486
26 Cabot Avenue
Santa Clara, CA 95051
Joseph O. Fletcher 2,794 1,118 1,676
1550 High Street
Boulder, CO 80304
Amy Gidday 419 168 251
16 Owl Drive
Louisville, Colorado 80027
Bruce Heitler 1,826 720 1,106
1410 Grant Street
Suite B203
Denver, CO 80203
George Holbrook, Jr. 5,448 2,179 3,269
107 John Street
Southport, CT 06490-0761
Christopher Johnson 4,191 1,676 2,515
2814 Condry Court
Boulder, Colorado 80301
Robert Keeley 7,218 2,800 4,418
12630 Milam Road
Colorado Springs, CO 80908
-5-
Shares To Shares
Shares Beneficially be Sold Beneficially
Owned in the Owned After
Selling Shareholder Prior to the Offering Offering the Offering
Kyle Lefkoff 279 112 167
Boulder Ventures
1634 Walnut
Suite 301
Boulder, CO 80301
Stefan A. Nyaradi 1,047 419 628
4669 Apple Way
Boulder, CO 80302
Mikhail & Olga Plam 69,850 15,950 53,900
345 Bluff
Boulder, CO 80304
Mikhail Plam 38,804 15,950 22,854
2345 Bluff
Boulder, CO 80304
James L.D. Roser 10,477 4,191 6,286
1105 Spruce
Boulder, CO 80302
James M. Schlater 26,275 3,000 23,275
3401 Ridgemont Drive
Mountain View, CA 94040
Randy Shearer 2,933 1,170 1,763
912 Palisade
Lawsville, CO 80027
Christine Sievers Spencer 419 168 251
3555 9th Street
Boulder, CO 80304
Christine Sievers Spencer
for Kelsey Spencer 419 168 251
3555 9th Street
Boulder, CO 80304
-6-
Shares To Shares
Shares Beneficially be Sold Beneficially
Owned in the Owned After
Selling Shareholder Prior to the Offering Offering the Offering
Curtis William Spencer 419 168 251
3555 9th Street
Boulder, CO 80304
Eric Louis Sievers 419 167 252
1213 E. Shelby Street
#9
Seattle, WA 98102
Henry Liborius Sievers 419 167 252
1120 North College Avenue
Tulsa, OK 74110
Lenna Lina Liu 419 167 252
1213 E. Shelby Street
#9
Seattle, WA 98102
Rosamond Wilcox Sievers 419 167 252
1120 North College Avenue
Tulsa, OK 74110
Robert E. & Nancy Sievers 66,916 26,767 40,149
655 North Star Court
Boulder, CO 80302
Frank Silvester 419 167 252
896 Inca Parkway
Boulder, CO 80303
Michael Stranahan 70,432 28,170 42,514
P.O. Box 15
Woody Creek, CO 81656
David Walters 419 167 252
2860 W. 116th Place #205
Westminster, Colorado 80234
-7-
Shares To Shares
Shares Beneficially be Sold Beneficially
Owned in the Owned After
Selling Shareholder Prior to the Offering Offering the Offering
Chris Wieland 698 279 419
21637 South Saint Vrain
Lyons, CO 80540
Walter & Elsie Wood 2,095 800 1,295
2303 Kalmia
Boulder, CO 80304
Stephen D. Wulchin 2,095 838 1,257
1138 Twin Peaks Circle
Longmont, CO 80503
</TABLE>
Each of the Selling Shareholders was a former shareholder of Sievers
Instruments, Inc., a Colorado corporation which was acquired by the Company
on May 31, 1996. The Selling Shareholders acquired their Shares from the
Company in a non-public offering pursuant to Rule 506 under Regulation D
under the Securities Act.
PLAN OF DISTRIBUTION
The Shares offered hereby may be sold from time to time by the Selling
Shareholders acting as principals for their own account. The Company is
responsible for all expenses incurred in connection with the registration
of the Shares. The Selling Shareholders will pay brokerage commissions or
other charges and expenses incurred in the sale of the Shares. The Company
has agreed to indemnify the Selling Shareholders against certain
liabilities, including liabilities under the Securities Act.
The distribution of the Shares by the Selling Shareholders is not
currently subject to any underwriting agreement. The Shares covered by
this Prospectus may be sold by the Selling Shareholders or by pledgees,
donees, transferees or other successors in interest from time to time, and
the Company believes that it is the intention of the Selling Shareholders
to complete such sales within ninety (90) days of the date of this
Prospectus. Such sales may be made at fixed prices that may be changed, at
market prices prevailing at the time of sale, at prices related to such
prevailing market prices, or at negotiated prices. Such sales may be
effected in the over-the-counter market, on the New York Stock Exchange or
on any other exchange on which the Shares may then be listed. The Shares
may be sold by one or more of the following: (a) one or more block trades
in which a broker or dealer so engaged will attempt to sell all or a
portion of the Shares held by the
-8-
Selling Shareholders as agent but may position and resell a portion of the
block as principal to facilitate the transaction; (b) purchases by a broker
or dealer as principal and resale by such broker or dealer for its account
pursuant to this Prospectus; and (c) ordinary brokerage transactions and
transactions in which the broker solicits purchasers. The Selling
Shareholders will effect such transactions by selling Shares through
broker-dealers, and such broker-dealers will receive compensation in
negotiated amounts in the form of discounts, concessions, commissions or
fees which will be paid by the Selling Shareholders. Such brokers or
dealers and the Selling Shareholders may be deemed to be "underwriters"
within the meaning of the Securities Act, in connection with such sales,
and any commissions received by such broker-dealers may be deemed to be
underwriting compensation. One or more Selling Shareholders may also
transfer some of their Shares by way of gift pursuant to this Prospectus.
The Company will provide a copy of this Prospectus to the New York
Stock Exchange pursuant to Rule 153 under the Securities Act.
State Street Bank & Trust Company, c/o Boston Equiserve, 150 Royall
Street, Canton, Massachusetts 02021, is the transfer agent for the
Company's Common Stock.
LEGAL MATTERS
Certain legal matters with respect to the issuance of the Shares are
being passed upon for the Company by Stephen Korn, Vice President and
General Counsel of the Company. Mr. Korn beneficially owns 43,281 shares
of Common Stock, which number includes 41,800 shares subject to options, as
to which Mr. Korn has the right to acquire beneficial ownership, and 258
shares (as of March 31, 1996) in the Company's Section 401(k) Plan for the
account of Mr. Korn.
EXPERTS
The consolidated financial statements and schedule of Ionics,
Incorporated and Subsidiaries as of December 31, 1995 and 1994, and for
each of the three years in the period ended December 31, 1995, incorporated
by reference in this Prospectus have been so incorporated herein in
reliance on the reports of Coopers & Lybrand L.L.P., independent
accountants, given on the authority of that firm as experts in accounting
and auditing.
-9-
No dealer, salesperson or any other
person has been authorized to give any
information or to make any representations
not contained in this Prospectus and, if
given or made, such information or
representations must not be relied upon
as having been authorized by the Company.
This Prospectus does not constitute an 145,754 Shares
offer to sell, or a solicitation of an
offer to sell, any securities other than
the registered securities to which it IONICS, INCORPORATED
relates, or an offer to or solicitation
of any person in any jurisdiction where
such an offer or solicitation would be
unlawful. Neither the delivery of this Common Stock
Prospectus nor any sale made hereunder
shall, under any circumstances, create
an implication that the information
contained herein is correct as of any
time subsequent to the date hereof.
_______________________________________
_____________________
TABLE OF CONTENTS
Page PROSPECTUS
_____________________
Available Information......... 2
Information Incorporated by
Reference.................... 2
The Company................... 3
Use of Proceeds............... 3
Selling Shareholders.......... 4
Plan of Distribution.......... 8
Legal Matters................. 9
Experts....................... 9 July 25, 1996
-10-